Free Trial

Integer (ITGR) Competitors

Integer logo
$105.44 -0.78 (-0.74%)
Closing price 09/9/2025 03:59 PM Eastern
Extended Trading
$105.48 +0.04 (+0.04%)
As of 09/9/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ITGR vs. BDSX, ELV, HOLX, BAX, GMED, MASI, TFX, ATEC, ATRC, and IART

Should you be buying Integer stock or one of its competitors? The main competitors of Integer include Biodesix (BDSX), Elevance Health (ELV), Hologic (HOLX), Baxter International (BAX), Globus Medical (GMED), Masimo (MASI), Teleflex (TFX), Alphatec (ATEC), AtriCure (ATRC), and Integra LifeSciences (IART). These companies are all part of the "medical" sector.

Integer vs. Its Competitors

Biodesix (NASDAQ:BDSX) and Integer (NYSE:ITGR) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

21.0% of Biodesix shares are owned by institutional investors. Comparatively, 99.3% of Integer shares are owned by institutional investors. 30.1% of Biodesix shares are owned by company insiders. Comparatively, 2.2% of Integer shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Integer has a net margin of 4.61% compared to Biodesix's net margin of -53.66%. Integer's return on equity of 12.27% beat Biodesix's return on equity.

Company Net Margins Return on Equity Return on Assets
Biodesix-53.66% -269.67% -43.94%
Integer 4.61%12.27%6.23%

Integer has higher revenue and earnings than Biodesix. Biodesix is trading at a lower price-to-earnings ratio than Integer, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biodesix$71.32M0.95-$42.93M-$0.29-1.60
Integer$1.72B2.15$119.90M$2.2746.45

In the previous week, Integer had 3 more articles in the media than Biodesix. MarketBeat recorded 8 mentions for Integer and 5 mentions for Biodesix. Biodesix's average media sentiment score of 1.47 beat Integer's score of 1.06 indicating that Biodesix is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biodesix
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Integer
6 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Biodesix currently has a consensus price target of $1.75, indicating a potential upside of 276.99%. Integer has a consensus price target of $140.25, indicating a potential upside of 33.02%. Given Biodesix's higher probable upside, equities analysts clearly believe Biodesix is more favorable than Integer.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biodesix
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80
Integer
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00

Biodesix has a beta of 1, meaning that its share price has a similar volatility profile to the S&P 500.Comparatively, Integer has a beta of 1.03, meaning that its share price is 3% more volatile than the S&P 500.

Summary

Integer beats Biodesix on 14 of the 17 factors compared between the two stocks.

Get Integer News Delivered to You Automatically

Sign up to receive the latest news and ratings for ITGR and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ITGR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ITGR vs. The Competition

MetricIntegerMED INSTRUMENTS IndustryMedical SectorNYSE Exchange
Market Cap$3.72B$7.02B$5.83B$21.32B
Dividend YieldN/A1.20%5.28%3.49%
P/E Ratio46.4526.4875.6929.42
Price / Sales2.15135.90544.7868.57
Price / Cash11.9322.1637.2024.61
Price / Book2.185.0411.504.55
Net Income$119.90M$176.38M$3.28B$999.91M
7 Day Performance-0.28%1.49%1.42%0.93%
1 Month Performance-0.91%4.82%11.28%5.24%
1 Year Performance-14.35%9.41%59.03%16.56%

Integer Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ITGR
Integer
4.142 of 5 stars
$105.44
-0.7%
$140.25
+33.0%
-15.3%$3.72B$1.72B46.4511,000Positive News
BDSX
Biodesix
3.4355 of 5 stars
$0.43
-4.4%
$1.75
+310.2%
-74.1%$62.55M$71.32M-1.47220Positive News
High Trading Volume
ELV
Elevance Health
4.7954 of 5 stars
$319.00
+2.8%
$413.81
+29.7%
-42.0%$71.75B$177.01B13.57104,200
HOLX
Hologic
4.8677 of 5 stars
$67.12
+0.8%
$78.00
+16.2%
-19.3%$14.93B$4.03B27.857,063Positive News
Analyst Upgrade
BAX
Baxter International
4.8561 of 5 stars
$24.72
+1.3%
$30.11
+21.8%
-37.6%$12.68B$10.64B-82.3838,000Positive News
GMED
Globus Medical
4.8727 of 5 stars
$61.26
+0.2%
$87.64
+43.1%
-15.6%$8.27B$2.52B23.565,300Positive News
MASI
Masimo
4.699 of 5 stars
$139.71
-0.9%
$193.60
+38.6%
+33.0%$7.59B$2.09B-16.405,600Positive News
TFX
Teleflex
4.6182 of 5 stars
$126.58
+0.3%
$141.57
+11.8%
-46.8%$5.59B$3.05B29.7814,100Positive News
Analyst Upgrade
ATEC
Alphatec
4.2325 of 5 stars
$15.90
-0.8%
$18.50
+16.4%
+179.6%$2.35B$611.56M-14.07700Analyst Upgrade
ATRC
AtriCure
3.5021 of 5 stars
$36.99
-0.6%
$50.89
+37.6%
+37.6%$1.84B$465.31M-48.041,300News Coverage
Positive News
IART
Integra LifeSciences
3.7227 of 5 stars
$15.13
+2.0%
$18.43
+21.8%
-12.2%$1.18B$1.61B-2.324,396Positive News

Related Companies and Tools


This page (NYSE:ITGR) was last updated on 9/10/2025 by MarketBeat.com Staff
From Our Partners